Free Image Courtesy of FreeDigitalPhotos.net

The signs of gynecological cancer can be elusive to most women.

The most common symptoms; fatigue, bloating and back pain, can be mistaken as benign annoyances which happen from time to time.

So, when do you need to be concerned that there may be something more serious which needs your attention?

There will be nearly 90,000 cases of gynecological cancers diagnosed in the U.S. in 2012, with more than half of those being cervical cancer, according to estimates from the National Cancer Institute. About 30,000 women will die of these five cancers this year; the deadliest of the five is ovarian cancer, which will cause about half of these deaths.

Knowing what is normal for you is the best way help your doctor monitor changes and what those changes may mean for your health.

Free Image Courtesy of FreeDigitalPhotos.net

Women are at much higher risk for contracting lung cancer and for women who have never smoked the rate of developing lung cancer is on the rise.

The American Association for Cancer Research has found that lung cancer tumors in non-smokers are different than tumors in smokers and they are trying to determine why.

The World Health Organization, WHO, recently classified diesel fumes as carcinogenic.

This might explain the rise along with other environmental factors.

“Not only has there been an increase in the number of women and non-smokers contracting the disease, but there has also been an increase in the number of cases diagnosed in stage 4 of the illness,” lead researcher Dr. Chrystèle Locher said in a statement.
This change — 58 percent with stage 4 in 2010 compared with 43 percent in 2000 — might reflect new classifications of different stages of the disease, the researchers said. They also found big changes in the type of cancer being diagnosed. The rate of people developing adenocarcinoma, a form of non-small cell lung cancer, jumped from 35.8 percent to 53.5 percent over the decade.

Free Image Courtesy of FreeDigitalPhotos.net

Researchers from the State University of New York at Stony Brook, last month, showed in a paper that tiny defects in the bulbs can let through UV light that can damage skin cells and lead to cancer.

The phosphorus coating inside the bulb contains the dangerous UV light rays, however, the curly shape of the bulbs creates opportunity for cracks in the coating allowing harmful rays to escape.

The researchers’ data, published in the journal Photochemistry and Photobiology, is preliminary, and based on experiments in a lab. In other words, there aren’t any known cases of sunburn from light bulbs yet. The researchers say it’s also not that hard to avoid the dangerous rays; they recommend putting the light behind glass or keeping a few feet away from the bulb.

While there is no need to panic it is simply one more thing to consider when trying to keep your family safe.

Free Image Courtesy of FreeDigitalPhotos.net

New technology enables a disposable wristband to read the amount of ultraviolet ( UV ) radiation to which you are being exposed.

In addition to sunscreen, the “UV Dosimeter” let’s you know when you’ve spent too much time in the sun; even with SPF protection.

At .15 cents per bracelet it is an affordable way to protect from yourself skin damage and skin cancer.

The wristbands contain an acid-release agent and a dye that work in concert to pick up UV light and then change color depending on the levels of radiation detected. Different bands will be tailored for people of varying skin types, who have different levels of UV tolerance. The band made for fair-skinned and fair-haired types will change color faster than bands made for darker-complected people.

In the U.S., skin cancer is the most common form of cancer, with more than 3.5 million cases diagnosed each year. Sunburn or overexposure to the sun is a major risk factor for developing skin cancer, and Intellego is betting that the worldwide market for the new wristband will be substantial.

The caffeine in coffee as well as in tea, soda and chocolate may be responsible for lowering the risk of Basal Cell Carcinoma ( BCC ).

A twenty year study has shown an inverse relationship between coffee drinkers and those who develop BCC.

“These results really suggest that it is the caffeine in coffee that is responsible for the decreased risk of basal cell carcinoma associated with increasing coffee consumption,” Jiali Han, associate professor at Brigham and Women’s Hospital, Harvard Medical School in Boston as well as the study’s lead author, said in a press release. “This would be consistent with published mouse data, which indicate caffeine can block skin tumor formation. However, more studies in different population cohorts and additional mechanistic studies will be needed before we can say this definitively.”

Along with sunscreen, limiting sun exposure and regular check-ups, caffeine could be an enjoyable way to help prevent skin cancer.

Health concerns top the list of reasons many gave for consuming less red meat.

With more evidence pointing to environmental factors for the rise in heart disease and many cancers, red meat has been at the center of the debate for quite some time.

“American culture has been a meat-and-potatoes culture for a very long time,” Fabius tells The Salt. “Now we’re in a period of believing that intake of meat should be reduced in this country; we’re talking about a generational transition.”

Among those who are eating less meat, 66 percent said they’re worried about the health effects; 47 percent said cost is a factor, while 30 percent were concerned about animal welfare, and 29 percent have limited their meat intake out of a concern for the environment.

Robert Lawrence, professor of environmental health sciences and director of the Center for a Livable Future at the Johns Hopkins School of Public Health, says this is consistent with what he found when he asked people in 2002 why they might eat less meat. “Health concerns still remain the No. 1 reason people might consider cutting back on meat,” says Lawrence, who helped launch the Meatless Monday initiative.

For women with faced with HER2-positive metastatic breast cancer trastuzumab emtansine, commonly referred to as T-DM1, will offer a very important therapeutic option.

The drug, trastuzumab emtansine, commonly referred to as T-DM1, appears to be superior to the standard treatment for women with advanced HER2-positive breast cancer. Researchers are presenting the results of a large three-year clinical trial Sunday at the 2012 American Society of Clinical Oncology conference in Chicago.

This two pronged approach to treating cancer offers an effective result with fewer side affects than traditional treatments.

Because the drug is delivered directly to the cancer and not into the blood stream the immune system has the opportunity to help fight the cancer.

As Western lifestyle habits extend into developing countries, so too, do the diseases which come with them.

In a paper from the World Health Organization’s International Agency for Research on Cancer (IARC) in Lyon, France the findings indicate that along with a rise in living standards, cancer will be on the rise.

A 75 percent increase in cancer by 2030 is expected in the developing world.

The researchers said that rising living standards in less developed countries would probably lead to a decrease in the number of infection-related cancers. But it was also likely there would also be an increase in types of the disease usually seen in richer countries.
They predicted that middle-income countries such as China, India and Africa could see an increase of 78 percent in the number of cancer cases by 2030.
Cases in less developed regions were expected to see a 93 percent rise over the same period, said the paper published in the journal Lancet Oncology.
Those rises would more than offset signs of a decline in cervical, stomach and other kinds of cancer in wealthier nations, said the researchers.

The most common types of cancer in the world are lung cancer, female breast cancer, colorectal cancer, stomach cancer, prostate cancer, liver cancer and cervical cancer.

Aspirin therapy for skin cancer has been suggested by a recent study to reduce the incidence of some skin cancers.

Study researcher, Sigrún Alba Jóhannesdóttir of Aarhus University Hospital in Denmark has found that aspirin and other similar anti-inflammatory painkillers such as ibuprofen and naproxen can lessen the risk of three major types of skin cancer

People who took NSAIDs did not seem to benefit from a reduced risk of developing basal cell carcinoma in general, although they did have a 15 percent and 21 percent reduced risk of developing this type of cancer on less-exposed sites (body areas other than the head and neck) when they took them long term or at high intensity, respectively.

Low incidence of side affects, affordability and availability make aspirin a promising tool in fighting one of the leading cancers.

Sunscreen, reduced time to sun exposure and a diet rich in vitamin A have also been shown to reduce skin cancers.

A test to detect the early signs of pancreatic cancer is good news for those at risk for the disease.

Known as one of the deadliest cancers, pancreatic cancer has, up to this point, been difficult to diagnose in it’s earliest stages when possible life saving treatment would be most effective.

In recent years, researchers have been investigating minimally invasive ways to find cancer by looking for so-called “field effects,” which are changes that occur in nearby tissues as a result of cancer growth. For instance, tumors require an increased blood supply. This means tissue in the vicinity of a cancer might have enlarged blood vessels, and a depletion of oxygen in the blood. Wallace likened the test to a metal detector that beeps faster the closer you get to the cancer.